Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10915-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10915-1-AP, RRID:AB_2086799
- Product name
- CTCF antibody
- Antibody type
- Polyclonal
- Description
- CTCF antibody (Cat. #10915-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references SMURF1 Regulates CTCF-HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma.
Cohesin prevents local mixing of condensed euchromatic domains in living human cells.
Regulatory elements in the Sox9 locus license the initiation of pancreatic ductal adenocarcinoma.
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling Suppression.
USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination.
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC.
Transcriptome sequencing analysis reveals a potential role of lncRNA NONMMUT058932.2 and NONMMUT029203.2 in abnormal myelin development of male offspring following prenatal PM(2.5) exposure.
A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19.
Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
Jin Y, Zhang T, Wu Z, Liang Y, Jiang Y, Yu G
Cancer science 2026 May;117(5):1346-1361
Cancer science 2026 May;117(5):1346-1361
Cohesin prevents local mixing of condensed euchromatic domains in living human cells.
Shimazoe MA, Iida S, Minami K, Higashi K, Tamura S, Kobayashi Y, Fujishiro S, Xiong L, Nakazato K, Ashwin SS, Nishiyama T, Nagata Y, Kanemaki MT, Kawaguchi A, Ohkawa Y, Schermelleh L, Toyoda A, Xie L, Kurokawa K, Ochiai H, Sasai M, Maeshima K
bioRxiv : the preprint server for biology 2026 Mar 2;
bioRxiv : the preprint server for biology 2026 Mar 2;
Regulatory elements in the Sox9 locus license the initiation of pancreatic ductal adenocarcinoma.
Ballester M, Kurilla A, Dai Y, Bergara-Muguruza L, Radke K, Maurer HC, Espinet E, Høj K, Marisch-Delgado A, Seymour PA, Omar S, Rift CV, Hasselby J, Klausen P, Vilmann P, Castellanos-Rubio A, Santin I, Sandelin A, Arnes L
Cell reports 2026 Apr 13;45(4):117176
Cell reports 2026 Apr 13;45(4):117176
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling Suppression.
Fu L, Liao W, Tan Y, Lin H, Ye K, Zhou X, Lin M, Huang K, Chen M, Wei J, Feng H, Chen Y, Chen J, Guan B, Li S, Zhang Z, Yu A, Feng Z, Zhang L, Shu G, Lu J, Chen W, Pan Y, Yang J, Luo J, Luo L
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Nov;12(44):e06367
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Nov;12(44):e06367
USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination.
Xie L, Song D, Ouyang Z, Ning Y, Liu X, Li L, Xia W, Yang Y
Cellular signalling 2025 Mar;127:111585
Cellular signalling 2025 Mar;127:111585
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC.
Zhao S, Sun J, Chang Q, Pang S, Zhang N, Fan Y, Liu J
Cancer cell international 2024 Sep 28;24(1):327
Cancer cell international 2024 Sep 28;24(1):327
Transcriptome sequencing analysis reveals a potential role of lncRNA NONMMUT058932.2 and NONMMUT029203.2 in abnormal myelin development of male offspring following prenatal PM(2.5) exposure.
Hou Y, Yan W, Li G, Sang N
The Science of the total environment 2023 Oct 15;895:165004
The Science of the total environment 2023 Oct 15;895:165004
A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19.
Chen T, Lin YX, Zha Y, Sun Y, Tian J, Yang Z, Lin SW, Yu F, Chen ZS, Kuang BH, Lei JJ, Nie YJ, Xu Y, Tian DB, Li YZ, Yang B, Xu Q, Yang L, Zhong N, Zheng M, Li Y, Zhao J, Zhang XY, Feng L
mBio 2021 Oct 26;12(5):e0137221
mBio 2021 Oct 26;12(5):e0137221
Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
Wang H, Yang B, Cai X, Cheng X, Shen N, Liu L, Li J, Wang Y, He H, Ying P, Li B, Lu Z, Yang N, Wang X, Zhang F, Li Y, Wang W, Ning C, Zhu Y, Chang J, Miao X, Tian J, Zhong R
Carcinogenesis 2021 Nov 12;42(11):1347-1356
Carcinogenesis 2021 Nov 12;42(11):1347-1356
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 10915-1-AP(CTCF antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-CTCF (IP:10915-1-AP, 5ug; Detection:10915-1-AP 1:300) with MCF-7 cells lysate 2560ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CTCF antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CTCF. This antibody recognizes human antigen. The CTCF antibody has been validated for the following applications: ELISA, WB, IHC, IP analysis.
